A novel molecular staging protocol for non-small cell lung cancer
- 8 April 1999
- journal article
- Published by Springer Nature in Oncogene
- Vol. 18 (14) , 2397-2404
- https://doi.org/10.1038/sj.onc.1202556
Abstract
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.Keywords
This publication has 20 references indexed in Scilit:
- Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancerOncogene, 1998
- KAI1 , a Metastasis Suppressor Gene for Prostate Cancer on Human Chromosome 11p11.2Science, 1995
- Mutations of the p53 Gene as a Predictor of Poor Prognosis in Patients With Non-Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 1993
- Retroviral Vector-Mediated Transduction of K-rasAntisense RNA into Human Lung Cancer Cells Inhibits Expression of the Malignant PhenotypeHuman Gene Therapy, 1993
- Suppression of cell motility and metastasis by transfection with human motility-related protein (MRP-1/CD9) DNA.The Journal of Experimental Medicine, 1993
- Correlation of Expression of H/LeY/LeBAntigens with Survival in Patients with Carcinoma of the LungNew England Journal of Medicine, 1992
- Identification of the motility-related protein (MRP-1), recognized by monoclonal antibody M31-15, which inhibits cell motility.The Journal of Experimental Medicine, 1991
- K-rasOncogene Activation as a Prognostic Marker in Adenocarcinoma of the LungNew England Journal of Medicine, 1990
- The ras Oncogenes Increase the Intrinsic Resistance of NIH 3T3 Cells to Ionizing RadiationScience, 1988
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958